Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana J Leeming

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|August 29, 2024
CTX-III in hepatitis CTea L Laursen, Mikkel B Kjær, Diana J Leeming, et al.
Cancer Metastasis Reviews|December 13, 2006
Biochemical approach to the detection and monitoring of metastatic bone disease: What do we know and what questions need answers?László B Tankó, Morten A Karsdal, Claus Christiansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2013
Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis--a serological evaluationDiana J Leeming, Inger Byrjalsen, Wladimiro Jiménez, et al.
Biochemistry|March 26, 2003
Phosphorylation of maize and Arabidopsis HMGB proteins by protein kinase CK2alphaChristian Stemmer, Diana J Leeming, Lars Franssen, et al.
Biomarker Insights|August 9, 2012
Molecular serum markers of liver fibrosisTianhui Liu, Xiaoming Wang, Morten A Karsdal, et al.
Plos One|October 30, 2014
Association of versican turnover with all-cause mortality in patients on haemodialysisFederica Genovese, Morten A Karsdal, Diana J Leeming, et al.
Plos One|August 31, 2013
Association of systemic collagen type IV formation with survival among patients undergoing hemodialysisDiana J Leeming, Morten A Karsdal, Lars M Rasmussen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2006
The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patientsDiana J Leeming, Mitsuru Koizumi, Inger Byrjalsen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2015
Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathyFederica Genovese, Peter Boor, Marios Papasotiriou, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung CancerNicholas Willumsen, Cecilie L Bager, Diana J Leeming, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Liver International : Official Journal of the International Association for the Study of the Liver|August 29, 2024
CTX-III in hepatitis CTea L Laursen, Mikkel B Kjær, Diana J Leeming, et al.
Cancer Metastasis Reviews|December 13, 2006
Biochemical approach to the detection and monitoring of metastatic bone disease: What do we know and what questions need answers?László B Tankó, Morten A Karsdal, Claus Christiansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2013
Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis--a serological evaluationDiana J Leeming, Inger Byrjalsen, Wladimiro Jiménez, et al.
Biochemistry|March 26, 2003
Phosphorylation of maize and Arabidopsis HMGB proteins by protein kinase CK2alphaChristian Stemmer, Diana J Leeming, Lars Franssen, et al.
Biomarker Insights|August 9, 2012
Molecular serum markers of liver fibrosisTianhui Liu, Xiaoming Wang, Morten A Karsdal, et al.
Plos One|October 30, 2014
Association of versican turnover with all-cause mortality in patients on haemodialysisFederica Genovese, Morten A Karsdal, Diana J Leeming, et al.
Plos One|August 31, 2013
Association of systemic collagen type IV formation with survival among patients undergoing hemodialysisDiana J Leeming, Morten A Karsdal, Lars M Rasmussen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2006
The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patientsDiana J Leeming, Mitsuru Koizumi, Inger Byrjalsen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2015
Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathyFederica Genovese, Peter Boor, Marios Papasotiriou, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung CancerNicholas Willumsen, Cecilie L Bager, Diana J Leeming, et al.
Pageof 11